about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Read More
1.78
0.01
(0.56%)
12,117
XNAS Volume
XNAS 11 Dec, 2025 11:12 AM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..